NICE reaches a deal with Roche on access to oral SMA drug Evrysdi
pharmaphorum
NOVEMBER 19, 2021
million price tag make it is the most expensive treatment ever approved for NHS funding. Roche said it is in discussions with the relevant authorities in Wales and Northern Ireland to try to extend the NICE guidance on risdiplam to these countries as quickly as possible.
Let's personalize your content